Evidence map›Paper›PMID 17568820›Full record

ArticleLeukemia2007

Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.

A M Glodek, Y Le, D M Dykxhoorn, S-Y Park, G Mostoslavsky, R Mulligan, J Lieberman, H E Beggs, M Honczarenko, L E Silberstein

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Saponins fromFrontiers in pharmacology · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

A M GlodekDepartment of Pathology, Joint Program in Transfusion Medicine, Children's Hospital Boston, Boston, MA, USA.
Y Le
D M Dykxhoorn
S-Y Park
G Mostoslavsky
R Mulligan
J Lieberman
H E Beggs
M Honczarenko
L E Silberstein
Harvard University · USBoston Children's Hospital · USFoundation for Biomedical Research · USUniversity of California, San Francisco · US

Funding

CENTER FOR HUMAN CELL THERAPYU24HL074355 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI SILBERSTEIN, LESLIE ERIC · 2004 to 2008
$11.6M
TRANSFUSION BIOLOGY AND MEDICINET32HL066987 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI JOHN P MANIS · 2001 to 2026
$10.2M
NHLBI NIH HHS T32 HL 066987-06NHLBI NIH HHS U24 HL074355-03
6 · The paper itself

Abstract

Hematopoietic stem/progenitor cells (HSC/P) reside in the bone marrow in distinct anatomic locations (niches) to receive growth, survival and differentiation signals. HSC/P localization and migration between niches depend on cell-cell and cell-matrix interactions, which result from the cooperation of cytokines, chemokines and adhesion molecules. The CXCL12-CXCR4 pathway, in particular, is essential for myelopoiesis and B lymphopoiesis but the molecular mechanisms of CXCL12 action remain unclear. We previously noted a strong correlation between prolonged CXCL12-mediated focal adhesion kinase (FAK) phosphorylation and sustained pro-adhesive responses in progenitor B cells, but not in mature B cells. Although FAK has been well studied in adherent fibroblasts, its function in hematopoietic cells is not defined. We used two independent approaches to reduce FAK expression in (human and mouse) progenitor cells. RNA interference (RNAi)-mediated FAK silencing abolished CXCL12-induced responses in human pro-B leukemia, REH cells. FAK-deficient REH cells also demonstrated reduced CXCL12-induced activation of the GTPase Rap1, suggesting the importance of FAK in CXCL12-mediated integrin activation. Moreover, in FAK(flox/flox) hematopoietic precursor cells, Cre-mediated FAK deletion resulted in impaired CXCL12-induced chemotaxis. These studies suggest that FAK may function as a key intermediary in signaling pathways controlling hematopoietic cell lodgment and lineage development.

Indexed as

Cell AdhesionChemotaxisAnimalsAntigens, LyB-LymphocytesCell DifferentiationChemokine CXCL12Chemokines, CXCColony-Forming Units AssayFocal Adhesion Protein-Tyrosine KinasesHematopoietic SystemHumansIntegrasesLentivirusMembrane ProteinsMiceAntigens, LyChemokine CXCL12Chemokines, CXCCre recombinaseCXCL12 protein, humanCxcl12 protein, mouseFocal Adhesion Protein-Tyrosine KinasesIntegrasesLy6a protein, mouseMembrane ProteinsProto-Oncogene Proteins c-kitrap1 GTP-Binding ProteinsReceptors, CXCR4

Identifiers

PMID17568820
OpenAlexW2129429514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.